Inventor · disambiguated record
Mark Uden
Also filed as: UDEN MARK
13 granted patents·6 pending applications·195 citations·filing 1998–2024
89Inventor score
Files withGAMMADELTA THERAPEUTICS LTD5GLAXOSMITHKLINE IP DEV LTD4OXFORD BIOMEDICA LTD3GLAXO GROUP LTD2ADAPTATE BIOTHERAPEUTICS LTD1
Top patents by PatentIndex Score
19 records- 0197US7303910B2Retroviral vectors comprising a functional splice donor site and a functional splice acceptor siteOXFORD BIOMEDICA LTD·Filed 2004·Granted Dec 4, 2007·137 cites·6 claims
- 0292US6783981B1Anti-viral vectorsOXFORD BIOMEDICA LTD·Filed 2000·Granted Aug 31, 2004·38 cites·22 claims
- 0373US11254753B2Antibodies with reduced binding to process impuritiesGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Feb 22, 2022·2 cites·14 claims
- 0470US12312408B2Multispecific anti-TCR delta variable 1 antibodiesGAMMADELTA THERAPEUTICS LTD·Filed 2023·Granted May 27, 2025·0 cites·14 claims
- 0570US11203632B2Antibody variantsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Dec 21, 2021·1 cites·7 claims
- 0670US2024376215A1Multispecific anti-tcr delta variable 1 antibodiesGAMMADELTA THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0767US9163249B2Production methodsUDEN MARK·Filed 2008·Granted Oct 20, 2015·2 cites·21 claims
- 0866US6808922B1Retroviral vectors comprising a functional splice donor site and a functional splice acceptor siteOXFORD BIOMEDICA LTD·Filed 1998·Granted Oct 26, 2004·14 cites·41 claims
- 0962US9534246B2Method for selecting high producing cell linesKOTSOPOULOU EKATERINI·Filed 2011·Granted Jan 3, 2017·1 cites·9 claims
- 1057US11566347B2Antibody variantsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 31, 2023·0 cites·20 claims
- 1151US2023028110A1Anti-tcr delta variable 1 antibodiesADAPTATE BIOTHERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1247US10633673B2Production methodsGLAXO GROUP LTD·Filed 2015·Granted Apr 28, 2020·0 cites·10 claims
- 1344US11098312B2Method of producing a recombinant proteinGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Aug 24, 2021·0 cites·19 claims
- 1443US2022403025A1Therapeutic uses of anti-tcr delta variable 1 antibodiesGAMMADELTA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1542US12460180B2Methods for isolating and expanding cellsGAMMADELTA THERAPEUTICS LTD·Filed 2019·Granted Nov 4, 2025·0 cites·16 claims
- 1638US2022010277A1Methods for isolating and expanding cellsGAMMADELTA THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1738US2002034393A1VectorFiled 2001·Application pending·0 cites
- 1835US2013310281A1Novel antigen binding proteinsHARDING EMMA R·Filed 2012·Application pending·0 cites
- 1933US11667887B2Method of producing a recombinant proteinGLAXO GROUP LTD·Filed 2016·Granted Jun 6, 2023·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Mark Uden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →